부산대학교 도서관

Maziarz, RT; Waller, EK; Jaeger, U; Fleury, I; McGuirk, J; Holte, H; Jaglowski, S; Schuster, SJ; Bishop, MR; Westin, JR

BLOOD ADVANCES. 4(4):629-637

Wieduwilt, Matthew J.; Metheny, Leland; Zhang, Mei-Jie; Wang, Hai-Lin; Estrada-Merly, Noel; Marks, David, I; Al-Homsi, A. Samer; Muffly, Lori; Chao, Nelson; Rizzieri, David; Gale, Robert Peter; Gadalla, Shahinaz M.; Cairo, Mitchell; Mussetti, Alberto; Gore, Steven; Bhatt, Vijaya Raj; Patel, Sagar S.; Michelis, Fotios, V; Inamoto, Yoshihiro; Badawy, Sherif M.; Copelan, Edward; Palmisiano, Neil; Kharfan-Dabaja, Mohamed A.; Lazarus, Hillard M.; Ganguly, Siddhartha; Bredeson, Christopher; Diaz Perez, Miguel Angel; Cassaday, Ryan; Savani, Bipin N.; Ballen, Karen; Martino, Rodrigo; Wirk, Baldeep; Bacher, Ulrike; Aljurf, Mahmoud; Bashey, Asad; Murthy, Hemant S.; Yared, Jean A.; Aldoss, Ibrahim; Farhadfar, Nosha; Liu, Hongtao; Abdel-Azim, Hisham; Waller, Edmund K.; Solh, Melhem; Seftel, Matthew D.; van der Poel, Marjolein; Grunwald, Michael R.; Liesveld, Jane L.; Kamble, Rammurti T.; McGuirk, Joseph; Munker, Reinhold; Cahn, Jean-Yves; Lee, Jong Wook; Freytes, Cesar O.; Krem, Maxwell M.; Winestone, Lena E.; Gergis, Usama; Nathan, Sunita; Olsson, Richard F.; Verdonck, Leo F.; Sharma, Akshay; Ringden, Olle; Friend, Brian D.; Cerny, Jan; Choe, Hannah; Chhabra, Saurabh; Nishihori, Taiga; Seo, Sachiko; George, Biju; Baxter-Lowe, Lee Ann; Hildebrandt, Gerhard C.; de Lima, Marcos; Litzow, Mark; Kebriaei, Partow; Hourigan, Christopher S.; Abid, Muhammad Bilal; Weisdorf, Daniel J.; Saber, Wael

Blood Advances. 6(1):339-357

Lazaryan, Aleksandr; Dolan, Michelle; Zhang, Mei-Jie; Wang, Hai-Lin; Kharfan-Dabaja, Mohamed A.; Marks, David, I; Bejanyan, Nelli; Copelan, Edward; Majhail, Navneet S.; Waller, Edmund K.; Chao, Nelson; Prestidge, Tim; Nishihori, Taiga; Kebriaei, Partow; Inamoto, Yoshihiro; Hamilton, Betty; Hashmi, Shahrukh K.; Kamble, Rammurti T.; Bacher, Ulrike; Hildebrandt, Gerhard C.; Stiff, Patrick J.; McGuirk, Joseph; Aldoss, Ibrahim; Beitinjaneh, Amer M.; Muffly, Lori; Vij, Ravi; Olsson, Richard; Byrne, Michael; Schultz, Kirk R.; Aljurf, Mahmoud; Seftel, Matthew; Savoie, Mary Lynn; Savani, Bipin N.; Verdonck, Leo F.; Cairo, Mitchell S.; Hossain, Nasheed; Bhatt, Vijaya Raj; Frangoul, Haydar A.; Abdel-Azim, Hisham; Al Malki, Monzr; Munker, Reinhold; Rizzieri, David; Khera, Nandita; Nakamura, Ryotaro; Ringden, Olle; van der Poel, Marjolein; Murthy, Hemant S.; Liu, Hongtao; Mori, Shahram; De Oliveira, Satiro; Bolanos-Meade, Javier; Elsawy, Mahmoud; Barba, Pere; Nathan, Sunita; George, Biju; Pawarode, Attaphol; Grunwald, Michael; Agrawal, Vaibhav; Wang, Youjin; Assal, Amer; Caro, Paul Castillo; Kuwatsuka, Yachiyo; Seo, Sachiko; Ustun, Celalettin; Politikos, Ioannis; Lazarus, Hillard M.; Saber, Wael; Sandmaier, Brenda M.; De Lima, Marcos; Litzow, Mark; Bachanova, Veronika; Weisdorf, Daniel

Haematologica. 105(5):1329-1338

Pasvolsky O; MD Anderson Cancer Center, Houston, TX, USA. opasvolsky@mdanderson.org.; Dima D; Fred Hutchinson Cancer Center, Seattle, WA, USA.; Cleveland Clinic Lerner College of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA.; Feng L; MD Anderson Cancer Center, Houston, TX, USA.; Dong W; MD Anderson Cancer Center, Houston, TX, USA.; Richards T; MD Anderson Cancer Center, Houston, TX, USA.; Davis JA; Medical University of South Carolina, Charleston, SC, USA.; Afrough A; Myeloma, Waldenstrom's, and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA.; Vazquez-Martinez M; Moffitt Cancer Center, Tampa, FL, USA.; Sannareddy A; Myeloma, Waldenstrom's, and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA.; Goel U; Cleveland Clinic Lerner College of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA.; Banerjee R; Fred Hutchinson Cancer Center, Seattle, WA, USA.; Khouri J; Cleveland Clinic Lerner College of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA.; Cervoni F; MD Anderson Cancer Center, Houston, TX, USA.; Gaballa MR; MD Anderson Cancer Center, Houston, TX, USA.; Lieberman-Cribbin A; Mount Sinai School of Medicine, New York, NY, USA.; Rana MS; Stanford University, Palo Alto, CA, USA.; Julian K; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; Ferreri CJ; Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC, USA.; Shune L; University of Kansas Medical Center, Kansas City, KS, USA.; DeJarnette S; University of Kansas Medical Center, Kansas City, KS, USA.; Bhurtel E; University of Kansas Medical Center, Kansas City, KS, USA.; Susanibar Adaniya S; Abramson Cancer Center and Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Portuguese A; Fred Hutchinson Cancer Center, Seattle, WA, USA.; Hosoya H; Stanford University, Palo Alto, CA, USA.; Mikkilineni L; Stanford University, Palo Alto, CA, USA.; Kaur G; Myeloma, Waldenstrom's, and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA.; Rossi A; Mount Sinai School of Medicine, New York, NY, USA.; Herr MM; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Schrum D; Duke University Cancer Institute, Durham, NC, USA.; Lin C; Duke University Cancer Institute, Durham, NC, USA.; Raza S; Cleveland Clinic Lerner College of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA.; Lin Y; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Midha S; Dana-Farber Cancer Institute, Boston, MA, USA.; Omar N; Dana-Farber Cancer Institute, Boston, MA, USA.; Atarsh S; Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC, USA.; McGuirk J; University of Kansas Medical Center, Kansas City, KS, USA.; Sborov D; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; Voorhees P; Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC, USA.; Anwer F; Cleveland Clinic Lerner College of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA.; Alsina M; Moffitt Cancer Center, Tampa, FL, USA.; Freeman C; Moffitt Cancer Center, Tampa, FL, USA.; Garfall AL; Abramson Cancer Center and Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Razzo BM; Abramson Cancer Center and Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Sidana S; Stanford University, Palo Alto, CA, USA.; Cowan AJ; Fred Hutchinson Cancer Center, Seattle, WA, USA.; Anderson LD Jr; Myeloma, Waldenstrom's, and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA.; Hansen DK; Moffitt Cancer Center, Tampa, FL, USA.; Richard S; Mount Sinai School of Medicine, New York, NY, USA.; Patel KK; MD Anderson Cancer Center, Houston, TX, USA.; Lee HC; MD Anderson Cancer Center, Houston, TX, USA. hclee@mdanderson.org.; Grajales-Cruz A; Moffitt Cancer Center, Tampa, FL, USA.

Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

Merz M; Department of Hematology, Cellular Therapy, Hemasteseology and Infectious Disease, University Hospital of Leipzig and Fraunhofer IZI, Leipzig, Germany. maximilian.merz@medizin.uni-leipzig.de.; Dima D; Cleveland Clinic, Cleveland, OH, USA.; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, MO, USA.; Hashmi H; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, MO, USA.; The Medical University of South Carolina, Charleston, SC, USA.; Memorial Sloan Kettering Cancer Center, New York City, NY, USA.; Ahmed N; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, MO, USA.; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Westwood, KS, USA.; Stölzel F; University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.; Holderried TAW; Department of Hematology, Oncology, Stem Cell Transplantation, Immune and Cell Therapy, Clinical Immunology and Rheumatology, University Hospital Bonn, Bonn, Germany.; Fenk R; Heinrich Heine University, University Hospital Düsseldorf, Düsseldorf, Germany.; Müller F; Department of Internal Medicine 5, Haematology and Oncology, University Hospital of Erlangen, Friedrich-Alexander University of Erlangen-Nuremberg (FAU), Erlangen, Germany.; Tovar N; Hospital Clínic de Barcelona. IDIBAPS. University of Barcelona, Barcelona, Spain.; Oliver-Cáldes A; Hospital Clínic de Barcelona. IDIBAPS. University of Barcelona, Barcelona, Spain.; Rathje K; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Davis JA; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, MO, USA.; The Medical University of South Carolina, Charleston, SC, USA.; Fandrei D; Department of Hematology, Cellular Therapy, Hemasteseology and Infectious Disease, University Hospital of Leipzig and Fraunhofer IZI, Leipzig, Germany.; Vucinic V; Department of Hematology, Cellular Therapy, Hemasteseology and Infectious Disease, University Hospital of Leipzig and Fraunhofer IZI, Leipzig, Germany.; Kharboutli S; Department of Internal Medicine 5, Haematology and Oncology, University Hospital of Erlangen, Friedrich-Alexander University of Erlangen-Nuremberg (FAU), Erlangen, Germany.; Baermann BN; Heinrich Heine University, University Hospital Düsseldorf, Düsseldorf, Germany.; Ayuk F; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Platzbecker U; Department of Hematology, Cellular Therapy, Hemasteseology and Infectious Disease, University Hospital of Leipzig and Fraunhofer IZI, Leipzig, Germany.; Albici AM; University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.; Schub N; University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.; Schmitz F; Department of Hematology, Oncology, Stem Cell Transplantation, Immune and Cell Therapy, Clinical Immunology and Rheumatology, University Hospital Bonn, Bonn, Germany.; Shune L; Cleveland Clinic, Cleveland, OH, USA.; Khouri J; Cleveland Clinic, Cleveland, OH, USA.; Anwer F; Cleveland Clinic, Cleveland, OH, USA.; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, MO, USA.; Raza S; Cleveland Clinic, Cleveland, OH, USA.; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, MO, USA.; McGuirk J; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, MO, USA.; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Westwood, KS, USA.; Mahmoudjafari Z; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, MO, USA.; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Westwood, KS, USA.; Green K; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, MO, USA.; The Medical University of South Carolina, Charleston, SC, USA.; Khandanpour C; Campus Lübeck, University Cancer Center Schleswig-Holstein and University of Lübeck, Lübeck, Germany.; Teichert M; Department of Medicine II, Division for Stem Cell Transplantation and Cellular Immunotherapy, Universitätsklinikum Essen, Essen, Germany.; Jeker B; Department of Medical Oncology, University Hospital Inselspital and University of Bern, Bern, Switzerland.; Hoffmann M; Department of Medical Oncology, University Hospital Inselspital and University of Bern, Bern, Switzerland.; Kröger N; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; von Tresckow B; Department of Medicine II, Division for Stem Cell Transplantation and Cellular Immunotherapy, Universitätsklinikum Essen, Essen, Germany.; de Larrea CF; Hospital Clínic de Barcelona. IDIBAPS. University of Barcelona, Barcelona, Spain.; Pabst T; Department of Medical Oncology, University Hospital Inselspital and University of Bern, Bern, Switzerland.; Abdallah AO; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, MO, USA.; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Westwood, KS, USA.; Gagelmann N; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

Graham, S. D.; Niroomand, D.; Ragan, R. J.; McGuirk, J. M.

Phys. Rev. A 97, 051603 (2018)

ariel: A Review of International English Literature. 54(1):163-166

Hammond, G; Bentley, MA; Becker, F; Grebosz, J; Taylor, MJ; Banu, A; Barton, CJ; Beck, T; Bednarczyk, P; Bracco, A; Bruce, AM; Bullock, LC; Burger, A; Camera, F; Chandler, C; Doornenbal, P; Gerl, J; Geissel, H; Gorska, M; Hellstrom, M; Judsond, D; Kojouharov, I; Kurz, N; Lozeva, R; Maj, A; Mandal, S; McGuirk, B; Muralithar, S; Paul, ES; Podolyak, Z; Prokopowicz, W; Rudolph, Dirk; Saito, N; Saito, TR; Schaffner, H; Simpson, J; Warner, DD; Weick, H; Weldon, C; Winkler, M; Wollersheim, HJ

Acta Physica Polonica. Series B: Elementary Particle Physics, Nuclear Physics, Statistical Physics, Theory of Relativity, Field Theory. 36(4):1253-1257

Bishop, M. R.; Dickinson, M.; Purtill, D.; Barba, P.; Santoro, A.; Hamad, N.; Kato, K.; Sureda, A.; Greil, R.; Thieblemont, C.; Morschhauser, Franck; Janz, M.; Flinn, I.; Rabitsch, W.; Kwong, Y. L.; Kersten, M. J.; Minnema, M. C.; Holte, H.; Chan, E. H. L.; Martinez-Lopez, J.; Müller, A. M. S.; Maziarz, R. T.; Mcguirk, J. P.; Bachy, E.; Le Gouill, S.; Dreyling, M.; Harigae, H.; Bond, D.; Andreadis, C.; Mcsweeney, P.; Kharfan-Dabaja, M.; Newsome, S.; Degtyarev, E.; Awasthi, R.; del Corral, C.; Andreola, G.; Masood, A.; Schuster, S. J.; Jäger, U.; Borchmann, P.; Westin, J. R.

Bishop, M R, Dickinson, M, Purtill, D, Barba, P, Santoro, A, Hamad, N, Kato, K, Sureda, A, Greil, R, Thieblemont, C, Morschhauser, F, Janz, M, Flinn, I, Rabitsch, W, Kwong, Y-L, Kersten, M J, Minnema, M C, Holte, H, Chan, E H L, Martinez-Lopez, J, Müller, A M S, Maziarz, R T, McGuirk, J P, Bachy, E, Gouill, S L, Dreyling, M, Harigae, H, Bond, D, Andreadis, C, McSweeney, P, Kharfan-Dabaja, M, Newsome, S, Degtyarev, E, Awasthi, R, del Corral, C, Andreola, G, Masood, A, Schuster, S J, Jäger, U, Borchmann, P & Westin, J R 2022, 'Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma', New England Journal of Medicine, vol. 386, no. 7, pp. 629-639. https://doi.org/10.1056/NEJMoa2116596

Galarza Fortuna GM; Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute at The University of Utah, Salt Lake City, UT.; Peres L; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL.; Nazarenko E; Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute at The University of Utah, Salt Lake City, UT.; De Menezes Silva Corraes A; Division of Hematology, Mayo Clinic, Rochester, MN.; Hovanky VN; Division of Transplantation and Cell Therapy, Stanford University School of Medicine, Stanford, CA.; Shune L; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas, Westwood, KS.; McGuirk J; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas, Westwood, KS.; De Avilla G; Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.; Khouri J; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.; Dima D; Department of Hematology and Medical Oncology, University of Washington, Fred Hutch Cancer Center, Seattle, WA.; Gaballa M; Division of Cancer Medicine, Department of Lymphoma-Myeloma, MD Anderson Cancer Center, Houston, TX.; Dhakal B; Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.; Forsberg P; Division of Hematologic/Oncology, University of Colorado Cancer Center, Denver, CO.; Godara A; Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute at The University of Utah, Salt Lake City, UT.; Afrough A; Hematologic Malignancies and Cellular Therapy Program, Section of Hematologic Malignancies and Cellular Therapy, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX.; Anderson LD Jr; Hematologic Malignancies and Cellular Therapy Program, Section of Hematologic Malignancies and Cellular Therapy, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX.; Herr MM; Division of Transplant and Cellular Therapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY.; Davis JA; Division of Hematology-Oncology, Medical University of South Carolina, Charleston, SC.; Mann H; Division of Hematology/Oncology, Virginia Commonwealth University, Richmond, VA.; Purvey S; Division of Hematology/Oncology, Virginia Commonwealth University, Richmond, VA.; Clark W; Division of Hematology/Oncology, Virginia Commonwealth University, Richmond, VA.; Htut M; Department of Hematology & Hematopoietic Cell Transplantation, Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA.; Beitinjaneh A; Division of Transplantation and Cellular Therapy, University of Miami, Miami, FL.; Pereira DL; Division of Transplantation and Cellular Therapy, University of Miami, Miami, FL.; Kocoglu MH; Division of Hematology/Oncology, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Ferreri CJ; Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC.; Atrash S; Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC.; Voorhees PM; Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC.; Rossi A; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.; Shambavi R; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.; Hashmi H; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY.; Patel K; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.; Sidana S; Division of Transplantation and Cell Therapy, Stanford University School of Medicine, Stanford, CA.; Lin Y; Division of Hematology, Mayo Clinic, Rochester, MN.; Hansen DK; Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.; Sborov DW; Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute at The University of Utah, Salt Lake City, UT.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Ahmed S; Division of Cancer Medicine, Departments of Lymphoma/Myeloma and Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX.; DiPersio J; Division of Oncology, Siteman Cancer Center, Washington University, St. Louis, MO.; Essell J; Oncology Hematology Care, Inc., Cincinnati, OH.; Diefenbach C; Division of Hematology and Medical Oncology, Department of Medicine, NYU Grossman School of Medicine, New York, NY.; Perales MA; Department of Medicine, Weill Cornell Medical College, Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Castilla-Llorente C; Department of Hematology, Gustave Roussy Cancer Campus Grand Paris, Villejuif, France.; Dahiya S; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA.; Liu Y; Research and Development, Nektar Therapeutics, San Francisco, CA.; Xu H; Research and Development, Nektar Therapeutics, San Francisco, CA.; Fanton C; Research and Development, Nektar Therapeutics, San Francisco, CA.; Chaudhry S; Research and Development, Nektar Therapeutics, San Francisco, CA.; Lee ZH; Research and Development, Nektar Therapeutics, San Francisco, CA.; Marcondes AMQ; Research and Development, Nektar Therapeutics, San Francisco, CA.; Tagliaferri MA; Research and Development, Nektar Therapeutics, San Francisco, CA.; Zalevsky J; Research and Development, Nektar Therapeutics, San Francisco, CA.; Miklos D; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA.; Turtle CJ; Fred Hutchinson Cancer Center, The University of Washington School of Medicine, Seattle, WA.; University of Sydney, Camperdown, Australia.; McGuirk J; Hematologic Malignancies and Cellular Therapeutics, Blood and Marrow Transplant, University of Kansas Medical Center, Kansas City, KS.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: In Process; MEDLINE

Sweiss K; University of Illinois at Chicago, Chicago, Illinois. Electronic address: ksweis2@uic.edu.; Wagner C; Huntsman Cancer Institute at the University of Utah, Salt Lake City, Utah.; Anto E; Huntsman Cancer Institute at the University of Utah, Salt Lake City, Utah.; Greene T; Huntsman Cancer Institute at the University of Utah, Salt Lake City, Utah.; Sun R; University of Illinois at Chicago, Chicago, Illinois.; Gonzalez R; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.; Puglianini OC; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.; Freeman C; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.; Ionescu F; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.; Patel K; The University of Texas MD Anderson Cancer Center, Houston, Texas.; Ferreri C; The University of Texas MD Anderson Cancer Center, Houston, Texas.; Gaballa M; The University of Texas MD Anderson Cancer Center, Houston, Texas.; Shune L; The University of Kansas Medical Center, Kansas City, Kansas.; McGuirk J; The University of Kansas Medical Center, Kansas City, Kansas.; Sidana S; Stanford University, Palo Alto, California.; Hovanky V; Stanford University, Palo Alto, California.; Khouri J; Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio.; Raza S; Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio.; Anwer F; Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio.; Dima D; Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio.; Hashmi H; Medical University of South Carolina, Charleston, South Carolina.; Davis J; Medical University of South Carolina, Charleston, South Carolina.; Afrough A; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Hematologic Malignancies and Cellular Therapy Program, Dallas, Texas.; Kaur G; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Hematologic Malignancies and Cellular Therapy Program, Dallas, Texas.; Anderson L Jr; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Hematologic Malignancies and Cellular Therapy Program, Dallas, Texas.; Forsberg P; UC Health Blood Disorders and Cell Therapies Center, Aurora, Colorado.; Herr M; Roswell Park Comprehensive Cancer Center, Buffalo, New York.; Hansen DK; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.; Hakan Kocoglu M; University of Maryland Marlene and Stewart Greenbaum Comprehensive Cancer Center, Baltimore, Maryland.; Sborov D; Huntsman Cancer Institute at the University of Utah, Salt Lake City, Utah.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

Ustun C; Division of Hematology/Oncology/Cell Therapy, Department of Medicine, Rush University, Chicago, Illinois, USA.; Zhang MJ; CIBMTR® (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, Wisconsin, USA.; Peterson A; CIBMTR® (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, Wisconsin, USA.; Baek A; CIBMTR® (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, Wisconsin, USA.; Agha M; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Alkhateeb H; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.; Chhabra S; Division of Hematology/Oncology, Department of Medicine, Mayo Clinic, Phoenix, Arizona, USA.; Coltoff A; Division of Hematology/Oncology, Department of Medicine, MUSC, Charleston, South Carolina, USA.; de Lima M; The James Comprehensive Cancer Center, Division of Hematology, The Ohio State University, Columbus, Ohio, USA.; Gandhi A; Knight Cancer Institute, Oregon Health & Science University, Oregon, Portland, USA.; Ho V; Division of Hematologic Malignancies, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Kassim A; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Lin A; Division of Hematology/Oncology, Department of Medicine, Northwestern Memorial Hospital, Chicago, Illinois, USA.; Gowda L; Hematology and Bone Marrow Transplantation, Yale University School of Medicine, New Haven, Connecticut, USA.; Borthakur G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; DeAngelo DJ; Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; McGuirk J; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mensah F; Hematology and Medical Oncology, Hematology, Medical Oncology, Fransciscan Health, Mishawaka, Indiana, USA.; Nadiminti KV; Carbone Cancer Center, Division of Hematology, Medical Oncology and Palliative Care, University of Wisconsin, Madison, Wisconsin, USA.; Nishihori T; Department of Blood & Marrow Transplant and Cellular Immunotherapy (BMT CI), Moffitt Cancer Center, Tampa, Florida, USA.; Pantin J; The Sarah Cannon Transplant and Cellular Therapy Program, TriStar Centennial Medical Center, Nashville, Tennessee, USA.; Trunk A; The University of Utah Transplant and Cellular Therapy Program, Salt Lake City, Utah, USA.; Uberti J; Karmanos Cancer Center, Hudson-Webber Cancer Research Center, Detroit, Michigan, USA.; Marcucci G; Department of Hematologic Malignancies Translational Science, Beckman Research Institute of City of Hope, Monrovia, California, USA.; Gotlib J; Division of Hematology, Stanford University School of Medicine, Stanford Cancer Institute, Stanford, California, USA.; Akin C; Division of Allergy and Clinical Immunology, Department of Medicine, University of Michigan, Ann Arbor, Michigan, USA.; Hamadani M; CIBMTR® (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, Wisconsin, USA.; Pullarkat V; Department of Hematologic Malignancies Translational Science, Beckman Research Institute of City of Hope, Monrovia, California, USA.; Valent P; Division of Hematology & Hemostaseology, Department of Internal Medicine I, and Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria.; Grunwald M; Department of Hematologic Oncology and Blood Disorders, Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, North Carolina, USA.; Juckett M; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, Minnesota, USA.; Oran B; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Saber W; CIBMTR® (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, Wisconsin, USA.; Burns LJ; CIBMTR® (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

Hill JA; Vaccine and Infectious Disease, Fred Hutchinson Cancer Center, and Department of Medicine, University of Washington, Seattle, Washington, USA.; Martens MJ; Center for International Blood and Marrow Transplantation Research, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.; Division of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.; Young JH; Division of Infectious Diseases, University of Minnesota, Minneapolis, Minnesota, USA.; Bhavsar K; Center for International Blood and Marrow Transplantation Research, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.; Kou J; Center for International Blood and Marrow Transplantation Research, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.; Chen M; Center for International Blood and Marrow Transplantation Research, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.; Lee LW; Adaptive Biotechnologies Corporation, Seattle, Washington, USA.; Baluch A; Division of Infectious Diseases, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.; Dhodapkar MV; Department of Hematology and Medical Oncology, School of Medicine, Emory University, Atlanta, Georgia, USA.; Nakamura R; Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, California, USA.; Peyton K; The Emmes Company, Rockville, Maryland, USA.; Howard DS; Division of Hematology and Oncology, Wake Forest Baptist, Winston-Salem, North Carolina, USA.; Ibrahim U; Division of Hematology and Medical Oncology, Mount Sinai Hospital, New York, New York, USA.; Shahid Z; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Armistead P; Division of Hematology, University of North Carolina Medical Center, Chapel Hill, North Carolina, USA.; Westervelt P; Division of Oncology, Barnes-Jewish Hospital, Washington University, St. Louis, Missouri, USA.; McCarty J; Division of Hematology, Oncology & Palliative Care, Virginia Commonwealth University, Richmond, Virginia, USA.; McGuirk J; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas, Lawrence, Kansas, USA.; Hamadani M; Division of Hematology & Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.; DeWolf S; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Hosszu K; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Sharon E; National Cancer Institute, Bethesda, Maryland, USA.; Spahn A; National Marrow Donor Program/Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota, USA.; Toor AA; Lehigh Valley Health Network, Allentown, Pennsylvania, USA.; Waldvogel S; National Marrow Donor Program/Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota, USA.; Greenberger LM; The Leukemia and Lymphoma Society, Rye Brook, New York, New York, USA.; Auletta JJ; National Marrow Donor Program/Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota, USA.; Division of Hematology/Oncology/BMT and Infectious Diseases, Nationwide Children's Hospital, Columbus, Ohio, USA.; Horowitz MM; Center for International Blood and Marrow Transplantation Research, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.; Riches ML; Center for International Blood and Marrow Transplantation Research, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.; Perales MA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Medicine, Weill Cornell Medical College, New York, New York, USA.

Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE

Mahmoudjafari Z; The University of Kansas Cancer Center, Kansas City, Kansas. Electronic address: zmahmoudjafari@kumc.edu.; McGuirk J; The University of Kansas Cancer Center, Kansas City, Kansas.; Ahmed N; The University of Kansas Cancer Center, Kansas City, Kansas.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

Durfee, D.; Fixler, J.; Foster, G.; Gustavson, T.; Landragin, A.; McGuirk, J.; Kasevich, M.

IEEE 2000. Position Location and Navigation Symposium (Cat. No.00CH37062) Position location and navigation symposium Position Location and Navigation Symposium, IEEE 2000. :395-398 2000

Irfan S; Aga Khan University, Karachi, Pakistan. Electronic address: sohaibirfan910@gmail.com.; Ayoobkhan FS; Trinity Health Oakland/Wayne State University, Pontiac, Michigan.; Vojjala N; Trinity Health Oakland/Wayne State University, Pontiac, Michigan.; Qureshi R; University of Missouri-Kansas City, Kansas City, Missouri.; Rahman R; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, Kansas.; Kamboj I; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, Kansas; U.S. Myeloma Innovations Research Collaborative (USMIRC), Kansas City, Kansas State.; Abdallah AO; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, Kansas; U.S. Myeloma Innovations Research Collaborative (USMIRC), Kansas City, Kansas State.; McGuirk J; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, Kansas.; Mahmoudjafari Z; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, Kansas.; Lutfi F; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, Kansas.; Ahmed N; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, Kansas.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

Graham, S. D.; McGuirk, J. M.

Phys. Rev. A 95, 023602 (2017)

Snyder J; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS 66205, USA.; Atrash S; Levine Cancer Center, Atrium Health, Wake Forest University School of Medicine, Charlotte, NC 27103, USA.; Paul B; Levine Cancer Center, Atrium Health, Wake Forest University School of Medicine, Charlotte, NC 27103, USA.; Khan AM; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.; Habib A; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS 66205, USA.; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.; Shaikh H; Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA 52242, USA.; Strouse C; Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA 52242, USA.; Alkharabsheh O; Division of Hematology and Oncology, Mitchell Cancer Institute, University of South Alabama, Mobile, AL 36604, USA.; Mazloom A; Division of Hematology and Oncology, Mitchell Cancer Institute, University of South Alabama, Mobile, AL 36604, USA.; Ahmed N; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS 66205, USA.; Mahmoudjafari Z; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS 66205, USA.; Mushtaq MU; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS 66205, USA.; Zayad A; Department of Internal of Medicine, Hamad Medical Corporation, Doha P.O. Box 3050, Qatar.; McGuirk J; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS 66205, USA.; Tiger YK; Division of Blood Disorders, Rutgers Cancer Institute, New Brunswick, NJ 08903, USA.; Shah MR; Division of Blood Disorders, Rutgers Cancer Institute, New Brunswick, NJ 08903, USA.; Abdallah AO; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS 66205, USA.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

Jimenez, Antonio M. Jimenez; De Lima, Marcos; Komanduri, Krishna, V; Wang, Trent P.; Zhang, Mei-Jie; Chen, Karen; Abdel-Azim, Hisham; Abid, Muhammad Bilal; Aljurf, Mahmoud; Alkhateeb, Hassan; Assal, Amer; Bacher, Ulrike; Baron, Frederic; Battiwalla, Minoo; Beitinjaneh, Amer; Bejanyan, Nelli; Bhatt, Vijaya Raj; Byrne, Michael; Cahn, Jean-Yves; Cairo, Mitchell; Castillo, Paul; Copelan, Edward; DeFilipp, Zachariah; Diaz Perez, Miguel Angel; Elsawy, Mahmoud; Gale, Robert Peter; George, Biju; Grunwald, Michael R.; Hildebrandt, Gerhard C.; Hogan, William J.; Kanakry, Christopher G.; Kansagra, Ankit; Kharfan-Dabaja, Mohamed A.; Khera, Nandita; Krem, Maxwell M.; Lazaryan, Aleksandr; Maakaron, Joseph; Martino, Rodrigo; McGuirk, Joseph; Michelis, Fotios, V; Milone, Giuseppe; Mishra, Asmita; Murthy, Hemant S.; Mussetti, Alberto; Nathan, Sunita; Nishihori, Taiga; Olsson, Richard; Palmisiano, Neil; Patel, Sagar; Saad, Ayman; Seo, Sachiko; Sharma, Akshay; Solh, Melhem; Verdonck, Leo F.; Wirk, Baldeep; Yared, Jean A.; Litzow, Mark; Kebriaei, Partow; Hourigan, Christopher S.; Saber, Wael; Weisdorf, Daniel

Bone Marrow Transplantation. 56(12):3068-3077